The seizure-related phenotype of brain-derived neurotrophic factor knockdown mice

被引:26
作者
Barton, ME [1 ]
Shannon, HE [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Neurosci Res Div, Indianapolis, IN 46285 USA
关键词
epilepsy; seizures; kindling; kainate; clonic-tonic seizures; limbic seizures;
D O I
10.1016/j.neuroscience.2005.08.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present investigation focused on the seizurerelated phenotype of mice lacking one allele of brain-derived neurotrophic factor. Thresholds for producing seizures in brain-derived neurotrophic factor wild-type and brain-derived neurotrophic factor heterozygous mice were compared in several seizure models, including thresholds for electrically-induced clonic, tonic-clonic and 6 Hz limbic seizures, as well as seizures induced chemically by kainate, pilocarpine and pentylenetetrazol. In addition, the rate of amygdala kindling, as well as pre- and post-kindling seizure thresholds was determined. Seizure thresholds for clonic and tonic-clonic electrically induced seizures did not differ between brain-derived neurotrophic factor wild-type and heterozygous mice. However, heterozygous mice had higher thresholds for 6 Hz limbic seizures compared with wild-type mice. Heterozygous mice also required larger doses of kainate to produce limbic seizures, Somewhat surprisingly, heterozygous mice required significantly lower doses of pilocarpine to produce limbic seizures. However, heterozygous mice required a higher dose of pentylenetetrazol to induce twitches, but not clonic seizures, compared with wild-type mice. In addition, heterozygous mice required more current to elicit focal after-discharges in the amygdala both pre- and post-kindling than did wild-type mice, and, heterozygous mice kindled more slowly than wild-type mice. The present findings provide additional support for the hypothesis that brain-derived neurotrophic factor is involved not only in normal excitability, but may also be involved in abnormal excitability such as occurs in seizure disorders and epileptogenesis. (c) 2005 Published by Elsevier Ltd on behalf of IBRO.
引用
收藏
页码:563 / 569
页数:7
相关论文
共 48 条
[41]  
SchmidtKastner R, 1996, EXP BRAIN RES, V107, P331
[42]  
Tanaka T, 1997, J NEUROSCI, V17, P2959
[43]   Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis [J].
Tongiorgi, E ;
Armellin, M ;
Giulianini, PG ;
Bregola, G ;
Zucchini, S ;
Paradiso, B ;
Steward, O ;
Cattaneo, A ;
Simonato, M .
JOURNAL OF NEUROSCIENCE, 2004, 24 (30) :6842-6852
[44]   Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: Temporal evolution of changes as compared to neuropeptide Y [J].
Vezzani, A ;
Ravizza, T ;
Moneta, D ;
Conti, M ;
Borroni, A ;
Rizzi, M ;
Samanin, R ;
Maj, R .
NEUROSCIENCE, 1999, 90 (04) :1445-1461
[45]  
White HS, 1998, NEUROPHARMACOLOGY ME, P27
[46]  
WOODBURY LA, 1952, ARCH INT PHARMACOD T, V92, P97
[47]   The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes [J].
Xu, B ;
Michalski, B ;
Racine, RJ ;
Fahnestock, M .
NEUROSCIENCE, 2004, 126 (03) :521-531
[48]   INTERPLAY BETWEEN GLUTAMATE AND GAMMA-AMINOBUTYRIC-ACID TRANSMITTER SYSTEMS IN THE PHYSIOLOGICAL REGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND NERVE GROWTH-FACTOR SYNTHESIS IN HIPPOCAMPAL-NEURONS [J].
ZAFRA, F ;
CASTREN, E ;
THOENEN, H ;
LINDHOLM, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10037-10041